The cardiovascular and renal effects of ANP and BNP and the action of these natriuretic peptides in manipulating the renin-angiotensin-aldosterone axis may help to prevent serious AKI in the management of patients with cardio-renal syndrome. This evidence concerns the gene NPPA and acute kidney injury.